Shares of Spire Healthcare Group PLC (LON:SPI) have earned an average recommendation of “Hold” from the eight ratings firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is GBX 304.29 ($4.20).

A number of brokerages recently issued reports on SPI. Barclays began coverage on Spire Healthcare Group in a research report on Friday, February 2nd. They set an “equal weight” rating and a GBX 270 ($3.73) price objective for the company. Liberum Capital raised their price objective on Spire Healthcare Group from GBX 270 ($3.73) to GBX 275 ($3.80) and gave the stock a “hold” rating in a research report on Friday, January 26th. Numis Securities reissued an “add” rating and set a GBX 296 ($4.09) price objective on shares of Spire Healthcare Group in a research report on Tuesday, January 16th. JPMorgan Chase & Co. reissued a “neutral” rating and set a GBX 339 ($4.68) price objective on shares of Spire Healthcare Group in a research report on Thursday, January 4th. Finally, Jefferies Group raised Spire Healthcare Group to a “buy” rating and raised their price objective for the stock from GBX 259 ($3.58) to GBX 290 ($4.01) in a research report on Wednesday, January 17th.

In other news, insider Peter R. Bamford bought 5,000 shares of the company’s stock in a transaction on Monday, November 27th. The stock was bought at an average cost of GBX 240 ($3.32) per share, with a total value of £12,000 ($16,579.17). Also, insider Justin Ash bought 84,500 shares of the company’s stock in a transaction on Thursday, November 23rd. The stock was purchased at an average cost of GBX 237 ($3.27) per share, with a total value of £200,265 ($276,685.55).

Shares of Spire Healthcare Group (LON:SPI) traded up GBX 1.40 ($0.02) during trading hours on Tuesday, hitting GBX 224 ($3.09). The company had a trading volume of 590,772 shares, compared to its average volume of 971,702. The firm has a market cap of $898.42 and a P/E ratio of 3,200.00. Spire Healthcare Group has a 1 year low of GBX 218.20 ($3.01) and a 1 year high of GBX 362.10 ($5.00).

TRADEMARK VIOLATION NOTICE: “Spire Healthcare Group PLC (SPI) Given Average Rating of “Hold” by Brokerages” was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of international trademark & copyright law. The correct version of this news story can be read at https://theolympiareport.com/2018/02/13/spire-healthcare-group-plc-spi-given-average-rating-of-hold-by-brokerages.html.

About Spire Healthcare Group

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.